相关实验视频

Updated: Jul 8, 2025

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

一个基于细菌和化物的纳米粒子启动了巨细胞的重编程,并促进了抗瘤表型

Rydell Alvarez-Arzola¹, Liliana Oliver¹, Michelle M Messmer²

¹Department of Immunoregulation, Immunology and Immunotherapy Direction, Center of Molecular Immunology, Havana, Cuba.

Journal of immunology (Baltimore, Md. : 1950)

|December 20, 2023

概括

这种新型免疫调节器非常小颗粒 (VSSP) 通过IRF8和PU.1重新编程与瘤相关的巨细胞,使其进入一种类似M1的抗瘤状态,从而增强抗癌反应.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
分子机制的分子机制

背景情况:

巨细胞是瘤微环境中的关键免疫细胞,经常采用原始的M2表型.
与瘤相关的巨细胞可以在功能上进行重新编程,从而提供治疗机会.
之前的研究确定了非常小的粒子 (VSSP) 作为影响髓状细胞分化的免疫调节剂.

研究的目的:

研究VSSP影响巨细胞两极化的机制.
测试VSSP是否驱使巨细胞进入一种类似M1的抗瘤状态.
为了确定VSSP诱导的M1极化是否增强了抗瘤反应.

主要方法:

利用小鼠模型研究巨细胞两极分化.
研究了IRF8和PU.1转录因子在VSSP介导作用中的作用.
在VSSP给药后,评估了内骨髓区的变化.

主要成果:

VSSP有效地将天真和M2极化巨细胞驱动到M1类功能状态.
由VSSP诱导的M1极化取决于转录因子IRF8和PU.1.
单剂VSSP治疗导致显著的抗瘤反应和改变了内髓质组成.

结论:

VSSP具有将巨细胞重新编程为抗瘤M1表型的能力.
IRF8和PU.1是VSSP对巨细胞两极分化影响的关键调解者.
通过调节髓状细胞功能,VSSP显示出作为增强抗瘤免疫力的治疗剂的潜力.

更多相关视频

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.